Candel Therapeutics, Inc. (CADL)
Candel Therapeutics, Inc. (CADL) Insider Trading
Directors, officers and holders of more than 10% of CADL report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 138 transactions on file: 1 with code P, 7 with code S and 42 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Manning Paul B | Director | A Award | 2,189 | $8.68 | $18,992 |
| Sep 30, 2026 | Loggia Nicoletta | Director | A Award | 380 | $8.68 | $3,297 |
| Sep 30, 2026 | PAPA JOSEPH C | Director | A Award | 1,325 | $8.68 | $11,496 |
| Sep 11, 2026 | Tak Paul Peter | Chief Executive Officer | S Sale | 59,379 | $10.46 | $620,891 |
| Sep 10, 2026 | Tak Paul Peter | Chief Executive Officer | M Exercise | 125,000 | $1.55 | $193,750 |
| Sep 10, 2026 | Tak Paul Peter | Chief Executive Officer | M Exercise | 125,000 | Not measured | Not measured |
| Sep 10, 2026 | Tak Paul Peter | Chief Executive Officer | S Sale | 220,866 | $11.50 | $2,539,893 |
| Sep 8, 2026 | Zimmermann Martine | Director | A Award | 64,000 | Not measured | Not measured |
| Aug 17, 2026 | Tyagarajan Seshu | Chief Technology Officer | S Sale | 7,000 | $12.00 | $84,000 |
| Jul 6, 2026 | Sims Mark E. | Chief Commercial Officer | A Award | 285,000 | Not measured | Not measured |
| Jun 30, 2026 | PAPA JOSEPH C | Director | A Award | 1,331 | $8.64 | $11,499 |
| Jun 30, 2026 | Manning Paul B | Director | A Award | 2,199 | $8.64 | $18,997 |
| Jun 30, 2026 | Loggia Nicoletta | Director | A Award | 381 | $8.64 | $3,291 |
| Jun 29, 2026 | Tyagarajan Seshu | Chief Technology Officer | S Sale | 7,000 | $10.02 | $70,151 |
| Jun 29, 2026 | Barone Francesca | Chief Scientific Officer | S Sale | 23,447 | $10.06 | $235,769 |
| Jun 23, 2026 | Martell Christopher | Director | A Award | 32,000 | Not measured | Not measured |
| Jun 23, 2026 | Radhakrishnan Maha | Director | A Award | 32,000 | Not measured | Not measured |
| Jun 23, 2026 | Nguyen Diem | Director | A Award | 32,000 | Not measured | Not measured |
| Jun 23, 2026 | Gaeta Renee | Director | A Award | 32,000 | Not measured | Not measured |
| Jun 23, 2026 | Nabel Gary J. | Director | A Award | 32,000 | Not measured | Not measured |
| Jun 23, 2026 | Benz Edward J. JR | Director | A Award | 32,000 | Not measured | Not measured |
| Jun 23, 2026 | Manning Paul B | Director | A Award | 32,000 | Not measured | Not measured |
| Jun 23, 2026 | PAPA JOSEPH C | Director | A Award | 32,000 | Not measured | Not measured |
| Jun 23, 2026 | Loggia Nicoletta | Director | A Award | 32,000 | Not measured | Not measured |
| Mar 31, 2026 | Loggia Nicoletta | Director | A Award | 779 | $4.11 | $3,205 |
| Mar 31, 2026 | PAPA JOSEPH C | Director | A Award | 2,795 | $4.11 | $11,499 |
| Mar 31, 2026 | Manning Paul B | Director | A Award | 4,618 | $4.11 | $18,998 |
| Feb 23, 2026 | Manning Paul B | Director | P Purchase | 550,458 | $5.45 | $2,999,996 |
| Jan 26, 2026 | Barone Francesca | Chief Scientific Officer | A Award | 232,000 | Not measured | Not measured |
| Jan 26, 2026 | Nichols William Garrett | Chief Medical Officer | A Award | 136,500 | Not measured | Not measured |
| Jan 26, 2026 | Tyagarajan Seshu | Chief Technology Officer | A Award | 154,000 | Not measured | Not measured |
| Jan 26, 2026 | Schoch Charles | Chief Financial Officer | A Award | 232,000 | Not measured | Not measured |
| Jan 26, 2026 | Tak Paul Peter | Chief Executive Officer | A Award | 629,000 | Not measured | Not measured |
| Jul 28, 2025 | Nichols William Garrett | Chief Medical Officer | M Exercise | 937 | $1.29 | $1,209 |
| Jul 28, 2025 | Nichols William Garrett | Chief Medical Officer | M Exercise | 937 | Not measured | Not measured |
| Jul 28, 2025 | Nichols William Garrett | Chief Medical Officer | S Sale | 937 | $6.98 | $6,540 |
| Jun 30, 2025 | Nichols William Garrett | Chief Medical Officer | S Sale | 781 | $5.04 | $3,936 |
| Jun 30, 2025 | Nichols William Garrett | Chief Medical Officer | M Exercise | 781 | Not measured | Not measured |
| Jun 30, 2025 | Nichols William Garrett | Chief Medical Officer | M Exercise | 781 | $1.29 | $1,007 |
| Jun 25, 2025 | Schoch Charles | Chief Financial Officer | A Award | 5,353 | $4.67 | $24,999 |
| Jun 25, 2025 | Martell Christopher | Director | A Award | 111,349 | $4.67 | $520,000 |
| Jun 25, 2025 | Loggia Nicoletta | Director | A Award | 2,141 | $4.67 | $9,998 |
| Jun 25, 2025 | Tyagarajan Seshu | Chief Technology Officer | A Award | 5,353 | $4.67 | $24,999 |
| Jun 25, 2025 | PAPA JOSEPH C | Director | A Award | 64,239 | $4.67 | $299,996 |
| Jun 25, 2025 | Barone Francesca | Chief Scientific Officer | A Award | 4,282 | $4.67 | $19,997 |
| Jun 25, 2025 | Manning Paul B | Director | A Award | 1,070,663 | $4.67 | $4,999,996 |
| Jun 25, 2025 | Tak Paul Peter | Chief Executive Officer | A Award | 42,826 | $4.67 | $199,997 |
| Jun 25, 2025 | Nabel Gary J. | Director | A Award | 5,353 | $4.67 | $24,999 |
| Jun 20, 2025 | Schoch Charles | Chief Financial Officer | A Award | 50,000 | Not measured | Not measured |
| Jun 17, 2025 | Manning Paul B | Director | A Award | 14,240 | Not measured | Not measured |
The full Form 4 history is on the CADL company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.